39842 Federal Register / Vol. 87, No. 127 / Tuesday, July 5, 2022 / Notices 

2The HP, practice-level, and program 

implementation surveys will be administered with 

enrolled/participating HPs, office managers/ 

leadership of enrolled/participating practices, and 

project directors/principal investigators of the 2021 

PMHCA cooperative-agreement funded programs 

three times during the project period (2023, 2024, 

and 2025) for a total of up to three responses per 

respondent. The 2021 PMHCA Program 

Implementation SSIs and the Champion SSIs and 

FGDs will be administered to 2021 PMHCA 

cooperative agreement-funded project directors/ 

principal investigator and program champions once 

at the end of the data collection period. The 2021 

PMHCA Care Coordinator SSI will be administered 

twice, once at the beginning of the data collection 

period and once at the end of the data collection 

period. The number of responses per respondent 

varies for the Care Coordinator SSI between the 

2018 and 2019 PMHCA and 2018 MDRBD 

cooperative-agreement funded programs and the 

2021 PMHCA cooperative-agreement funded 

program because the 2018 and 2019 cooperativeagreement programs will end in 2023 whereas the 

2021 PMHCA cooperative agreement-funded 

programs will end in 2026. 

3The Community Resources SSI will be a case 

study with (1) up to 5 awardees who have identified 

up to 5 formal (i.e., there is a formal agreement, 

Memorandum of Understanding (MOU); 

Memorandum of Agreement (MOA); letter of 

support) community partnerships and (2) up to 5 

awardees who have identified up to 5 informal (i.e., 

there is no formal agreement, MOU; MOA; letter of 

support) community partnership; there will be up 

to 25 respondents for each group (i.e., formal, 

informal) for a total N=50. The Community 

Resource SSIs will be administered for the 2018 and 

2019 PMHCA and 2018 MDRBD cooperativeagreement funded programs at the end of the data 

collection period in Spring 2023 and for 2021 

PMHCA cooperative agreement-funded program at 

the end of the data collection period in Fall 2025. 

TOTAL ESTIMATED ANNUALIZED BURDEN HOURS

Form name Number of 

respondents 

Number of 

responses per 

respondent 2

Total 

responses 

Average 

burden 

per response 

(in hours) 

Total burden 

hours 

2021 PMHCA HP Survey .................................................... 8,029 3 24,087 .25 6,021.75 

2021 PMHCA Practice-Level Survey ................................... 2,950 3 8,850 .25 2,212.50 

2021 PMHCA Program Implementation Survey .................. 24 3 72 .33 23.76 

2021 PMHCA Program Implementation SSI ....................... 24 1 24 1.00 24.00 

2021 PMHCA Champion SSI .............................................. 48 1 48 .50 24 

2021 PMHCA Champion FGD ............................................. 24 1 24 1.00 24 

2021 PMHCA Community Resources SSI 3 ........................ 50 1 50 .50 25 

2021 PMHCA Care Coordinator SSI ................................... 24 2 48 .50 24 

2018/2019 PMHCA and 2018 MDRBD Champion SSI ....... 56 1 56 .50 28 

2018/2019 PMHCA and 2018 MDRBD Champion FGD ..... 28 1 28 1,00 28 

2018/2019 PMHCA and 2018 MDRBD Community Resources SSI 3 .................................................................... 50 1 50 .50 25 

2018/2019 PMHCA and 2018 MDRBD Care Coordinator 

SSI .................................................................................... 28 1 28 .50 14 

Total .............................................................................. 11,335 ........................ 33,365 ........................ 8,474.01 

HRSA specifically requests comments 

on (1) the necessity and utility of the 

proposed information collection for the 

proper performance of the agency’s 

functions, (2) the accuracy of the 

estimated burden, (3) ways to enhance 

the quality, utility, and clarity of the 

information to be collected, and (4) the 

use of automated collection techniques 

or other forms of information 

technology to minimize the information 

collection burden. 

Maria G. Button, 

Director, Executive Secretariat. 

[FR Doc. 2022–14184 Filed 7–1–22; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Committee on Vital and Health 

Statistics; Meeting 

AGENCY: Centers for Disease Control and 

Prevention, HHS. 

ACTION: Notice of meeting. 

SUMMARY: Pursuant to the Federal 

Advisory Committee Act, the 

Department of Health and Human 

Services (HHS) announces the following 

advisory committee meeting. This 

meeting is open to the public. The 

public is welcome to obtain the link to 

attend this meeting by following the 

instructions posted on the Committee 

website: https://ncvhs.hhs.gov/ 

meetings/full-committee-meeting-11/. 

DATES: The meeting will be held 

Wednesday, July 20, 2022: 10:30 a.m.– 

5:00 p.m. EDT and Thursday, July 21, 

2022: 10:30 a.m.–4:30 p.m. EDT. 

ADDRESSES: Virtual open meeting. 

FOR FURTHER INFORMATION CONTACT: 

Substantive program information may 

be obtained from Rebecca Hines, MHS, 

Executive Secretary, NCVHS, National 

Center for Health Statistics, Centers for 

Disease Control and Prevention, 3311 

Toledo Road, Hyattsville, Maryland 

20782, or via electronic mail to vgh4@

cdc.gov; or by telephone (301) 458– 

4715. Summaries of meetings and a 

roster of Committee members are 

available on the home page of the 

NCVHS website https://ncvhs.hhs.gov/, 

where further information including an 

agenda and instructions to access the 

broadcast of the meeting will be posted. 

Should you require reasonable 

accommodation, please telephone the 

CDC Office of Equal Employment 

Opportunity at (770) 488–3210 as soon 

as possible. 

SUPPLEMENTARY INFORMATION:

Purpose: As outlined in its Charter, 

the National Committee on Vital and 

Health Statistics assists and advises the 

Secretary of HHS on health data, data 

standards, statistics, privacy, national 

health information policy, and the 

Department’s strategy to best address 

those issues. At this meeting, the 

Committee will receive updates from 

HHS officials, hold discussions on 

current health data policy topics, and 

discuss its work plan for the upcoming 

period. 

The Subcommittee on Standards will 

provide an update from its June 9, 2022, 

Listening Session on Standardization of 

Information for Burden Reduction and 

Post-Pandemic America (‘‘Convergence 

2.0’’). The Subcommittee anticipates 

discussing draft recommendations with 

the full Committee developed as a result 

of a yearlong process. 

In addition, the Committee will hear 

an update on developments on uptake 

of International Classification of 

Diseases, 11th Revision (ICD–11) and 

briefings on various data privacy, 

confidentiality, and security 

developments to inform the workplan, 

which also will be discussed. The 

Committee’s Workgroup on Sexual 

Orientation and Gender Identity/Social 

Determinants of Health Data (SOGI/ 


lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 87, No. 127 / Tuesday, July 5, 2022 / Notices 39843 

SDOH) will give an update on recent 

activities and upcoming plans. 

The Committee will reserve time for 

public comment toward the end of the 

agenda on both days. Meeting times and 

topics are subject to change. Please refer 

to the agenda posted at the NCVHS 

website for this meeting at: https://

ncvhs.hhs.gov/meetings/full-committeemeeting-11/ for updates. 

Sharon Arnold, 

Associate Deputy Assistant Secretary for 

Planning and Evaluation, Science and Data 

Policy, Office of the Assistant Secretary for 

Planning and Evaluation. 

[FR Doc. 2022–14176 Filed 7–1–22; 8:45 am] 

BILLING CODE 4150–05–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Heart, Lung, and Blood 

Institute; Notice of Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Heart, Lung, 

and Blood Institute Special Emphasis Panel; 

OIA R35 Review Meeting. 

Date: August 4–5, 2022. 

Time: 11:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6705 

Rockledge Drive, Bethesda, MD 20817 

(Virtual Meeting). 

Contact Person: Kristen Page, Ph.D., 

Scientific Review Officer, Office of Scientific 

Review/DERA, National Heart, Lung, and 

Blood Institute, National Institutes of Health, 

6705 Rockledge Drive, Room 209–B, 

Bethesda, MD 20892, (301) 827–7953, 

kristen.page@nih.gov. 

Name of Committee: National Heart, Lung, 

and Blood Institute Special Emphasis Panel; 

Medical Students Research Training Program 

(T35). 

Date: August 9, 2022. 

Time: 1:00 p.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6705 

Rockledge Drive, Bethesda, MD 20817 

(Virtual Meeting). 

Contact Person: Kazuyo Kegan, Ph.D., 

Scientific Review Officer, Office of Scientific 

Review/DERA, National Heart, Lung and 

Blood Institute, National Institutes of Health, 

6705 Rockledge Drive, Room 208–S, 

Bethesda, MD 20817, (301) 435–0270, 

kazuyo.kegan@nih.gov. 

Name of Committee: National Heart, Lung, 

and Blood Institute Special Emphasis Panel; 

R13 Conference Grants. 

Date: August 25, 2022. 

Time: 1:00 p.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6705 

Rockledge Drive, Bethesda, MD 20817, 

(Virtual Meeting). 

Contact Person: Kazuyo Kegan, Ph.D., 

Scientific Review Officer, Office of Scientific 

Review/DERA, National Heart, Lung and 

Blood Institute, National Institutes of Health, 

6705 Rockledge Drive, Room 208–S, 

Bethesda, MD 20817, (301) 435–0270, 

kazuyo.kegan@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.233, National Center for 

Sleep Disorders Research; 93.837, Heart and 

Vascular Diseases Research; 93.838, Lung 

Diseases Research; 93.839, Blood 2Diseases 

and Resources Research, National Institutes 

of Health, HHS) 

Dated: June 29, 2022. 

David W. Freeman, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2022–14261 Filed 7–1–22; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Eunice Kennedy Shriver National 

Institute of Child Health and Human 

Development; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Child Health and Human Development 

Special Emphasis Panel; Biobehavioral and 

Behavioral Sciences Study Section. 

Date: August 3, 2022. 

Time: 11:00 a.m. to 12:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Eunice Kennedy Shriver National 

Institute of Child Health and Human 

Development, National Institutes of Health, 

6710B Rockledge Drive, Room 2127B, 

Bethesda, MD 20892 (Video Assisted 

Meeting). 

Contact Person: Chi-Tso Chiu, Ph.D., 

Scientific Review Officer, Scientific Review 

Branch (SRB), Eunice Kennedy Shriver 

National Institute of Child Health & Human 

Development, NIH, DHHS, 6710B Rockledge 

Drive, Rm 2127B, Bethesda, MD 20817, (301) 

435–7486, chiuc@mail.nih.gov. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.865, Research for Mothers 

and Children, National Institutes of Health, 

HHS) 

Dated: June 29, 2022. 

David W. Freeman, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2022–14263 Filed 7–1–22; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel 

Neuroimaging Technologies. 

Date: July 25, 2022. 

Time: 10:00 a.m. to 1:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892, (Virtual Meeting). 

Contact Person: Sharon S Low, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 


lotter on DSK11XQN23PROD with NOTICES1